Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aluminum hydroxide (in vaccine) |
Is a |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental aluminum hydroxide poisoning |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional aluminium hydroxide poisoning |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminum hydroxide poisoning of undetermined intent |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide adverse reaction |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminum hydroxide overdose |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental aluminum hydroxide overdose |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional aluminum hydroxide overdose |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminum hydroxide overdose of undetermined intent |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminum hydroxide [antacid] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminum hydroxide 500mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminum hydroxide oral suspension BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by aluminum hydroxide |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminum hydroxide [nutritional use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminium hydroxide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminum hydroxide+belladonna mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminum hydroxide+belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aluminium hydroxide and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental aluminum hydroxide poisoning |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional aluminium hydroxide poisoning |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide allergy |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aluminium hydroxide and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aluminium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminum hydroxide + dimethicone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminium hydroxide- and magnesium trisilicate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide allergy |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide dried gel |
Is a |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminium hydroxide hydrate |
Is a |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminum hydroxide 500mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminum hydroxide 500mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide hydrate |
Is modification of (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aluminium hydroxide- and belladonna alkaloid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has precise active ingredient |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminum hydroxide 500mg tablet (substance) |
Has precise active ingredient |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aluminium hydroxide and magnesium hydroxide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide gel |
Is modification of (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dried aluminium hydroxide gel (substance) |
Is modification of (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aluminium hydroxide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide and magnesium carbonate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aluminium hydroxide and belladonna alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide and magnesium hydroxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide and magnesium trisilicate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aluminium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide and magnesium hydroxide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aluminium hydroxide and dimeticone and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aluminium hydroxide and dimeticone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aluminium hydroxide 58.2 milligram/1 milliliter and magnesium hydroxide 19.6 milligram/1 milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aluminium hydroxide 58.2 milligram/1 milliliter and magnesium hydroxide 19.6 milligram/1 milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aluminium hydroxide anhydrous (substance) |
Is modification of (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aluminium hydroxide and magnesium hydroxide and simeticone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aluminium hydroxide and magnesium hydroxide and simeticone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aluminium hydroxide and dimeticone and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |